Register
Login:
Share:
Email Facebook Twitter

Be a contrarian investor says Ranjeet Singh Watch here

Be a contrarian investor says Ranjeet Singh


Provexis Share Chat (PXS)



Share Price: 0.5495Bid: 0.50Ask: 0.599Change: 0.00 (0.00%)No Movement on Provexis
Spread: 0.099Spread as %: 19.80%Open: 0.5495High: 0.5495Low: 0.5495Yesterday’s Close: 0.5495


Share Discussion for Provexis


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


gixer
Posts: 949
Off Topic
Opinion:No Opinion
Price:0.5495
RE: bloodflow health pill EFSA Appr..
Sun 13:57
We have a good head start in China as well as our man at By-Health is well up on Fruitflow.
He did work for us :-)

Xuguang Zhang
Director, Science and Technology Centre; Director, Nutrition and Health Research Centre
Company NameBy-Health Co., Ltd

Past
Senior Research Scientist/Project Manager
Company NamePROVEXIS PLC

https://www.linkedin.com/in/xuguang-zhang-a7ab8062/
 
KHammer
Posts: 20
Observation
Opinion:Hold
Price:0.5495
RE: bloodflow health pill EFSA Appr..
Sun 13:35
Dont read iii so missed your posts there, thanks for adding post here.

I dont think it matters that much if they work differently if they have similar effect/outcome.

We do seem to have a big head start and dsm pushing fruitflow, but even so we now have a competitor with EFSA approval.

Will hold for now in any case as already down and will be interesting to see what happens in China over next few years.
gixer
Posts: 949
Off Topic
Opinion:No Opinion
Price:0.5495
RE: bloodflow health pill EFSA Appr..
Sun 11:33
This is what i wrote when someone found it on iii last month

"Barry Callebaut got efsa approval on cocoa flavanols back in June 2012.

http://www.barry-callebaut.com/news/2012/07/efsa-issues-positive-scientific-opinion-barry-callebaut%E2%80%99s-health-claim-cocoa-flavanols

and then extended it in 2015

http://www.barry-callebaut.com/news/2015/04/european-commission-extends-barry-callebaut%E2%80%99s-health-claim-acticoa%C2%AE-products-extracts

Naturex then signed a deal with them at the end of 2015

http://www.nutraingredients.com/Suppliers2/Naturex-takes-Barry-Callebaut-cocoa-flavanols-to-the-supplements-aisles

and launched the first product 2016

http://www.nutritionaloutlook.com/heart-health/first-cocoa-extract-naturex-barry-callebaut-collaboration-hits-market

So far I am only aware of 1 or 2 products (could be more) containing cocoactiv the main one being from Cambridge Nutracuticals. (launched the start of February)

https://futureyouhealth.com/blood-flow.html

Requiring 2 capsules a day at £25 for a months supply I am not sure there is much competition at the moment. It also works differently to Fruitflow.

Fruitflow is well ahead at the moment and I see no reason that that will change any time soon.

Worried? Nah!"

P.S. It also works differently to fruitflow.
KHammer
Posts: 20
Observation
Opinion:Hold
Price:0.5495
RE: bloodflow health pill EFSA Appr..
Sun 09:58
KHammer
Posts: 20
Observation
Opinion:Hold
Price:0.5495
bloodflow health pill EFSA Approved
Sun 09:57
https://www.pressreader.com/uk/daily-mail/20170323/282724816754669

Ouch. Lets hope China doesnt hear about this one...

Not sure if its been posted before but read about it in today's Mail on Sunday....
pickledonion
Posts: 598
Off Topic
Opinion:No Opinion
Price:0.5495
RE: Pxs
Wed 16:06
Yes, early investment is key. Although I think I was 7-8 years early on my initial buy haha!
I only sold recently as the spikes were too good an opportunity to not take profit (for me). They generally follow positive news that when not backed up by an increase in revenue, tail off rather rapidly.
I'm also very interested in how things pan out in China, but with the By-Health collaboration at such an early stage, I'll risk being out for the potential benefit of a lower buy in price. Obviously, I could miss out big time, but with the SP not likely to drop much further (IMO), I'll likely begin buying back quite soon.
Oh, and we mustn't forget the blood pressure/memory trial results and to a lesser extent, the increased revenue from current streams. Although, I have to agree with one of Dampsquibs sentiments, that it's not the easiest product to market to the masses.
GCCRa
Posts: 386
Off Topic
Opinion:Strong Buy
Price:0.5495
View Thread (2)
RE: Pxs
Wed 08:25
Correct approach pickle. This stock has legs, albeit when our China strategy yields results. EARLY investment is key before the market kicks in....
pickledonion
Posts: 598
Off Topic
Opinion:No Opinion
Price:0.5495
View Thread (6)
RE: Pxs
Tue 18:03
It's a shame for others, but I shall continue to call out Trolls such as yourself whenever I see them.
It's clear to all that you're only here to antagonise Alfista, and to dress it up as saving people from making poor investment choices, is an insult to their intelligence.
giantsquid
Posts: 589
Off Topic
Opinion:No Opinion
Price:0.5495
View Thread (3)
RE: Pxs
Tue 17:45
pickledonion, with regard WRN, there are currently multiple legal cases underway due to the tortious inference/corporate sabotage of the company. A tortious interference report "TIR" has been produced in which bulletin board trolls, the worst offenders, are to be pursued as part of the interferents. Whether or not all of this will involve alfista I've no idea, that's for the company to decide. Clearly, with active legal cases underway, it's probably wise to stay out of it and not comment.
alfista
Posts: 14,494
Off Topic
Opinion:No Opinion
Price:0.5495
View Thread (3)
RE: Pxs
Tue 17:33
My comments here, and on any other board, are just the opinions of one person.
Absolutely none have been defamatory, I had a bearish view of Worthington based on my own analysis, and now it is in liquidation,
So.....




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.